Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter?

Diabetic Medicine

Volumn 20, Issue 11, 2003, Pages 915-920

  Williams, J W ^a   Zimmet, P Z ^a   Shaw, J E ^a   De Courten, M P ^a   Cameron, Adrian J ^a   Chitson, P ^b   Tuomilehtot, J ^c   Alberti, K G M M ^d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Ministry of Health and Quality of Life   (Mauritius)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Diabetes; Gender; Impaired fasting glucose; Impaired glucose tolerance; Mauritius

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; COMMUNITY CARE; DIABETES MELLITUS; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; IMPAIRED GLUCOSE TOLERANCE; MAURITIUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; BODY CONSTITUTION; BODY MASS; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE TOLERANCE TEST; MALE; METHODOLOGY; MIDDLE AGED; SEX RATIO;

ADULT; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HUMANS; MALE; MAURITIUS; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION;

EID: 1542603262     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01059.x     Document Type: Article

References (31)

1. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
2. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications; Part 1: Diagnosis and Classification of Diabetes Mellitus. Report no.: WHO/NCD/NCS/99.2. Geneva: Department of Noncommunicable Disease Surveillance, 1999.
3. Charles M, Fontbonne A, Thibult N, Warnet J-M, Rosselin G, Eschwege E. Risk factors for NIDDM in white population. Paris Prospective Study. Diabetes 1991; 40: 796-799.
4. Edelstein S, Knowler W, Bain R, Andres R, Barren-Connor E, Dowse G et al. Predictors of progression from impaired glucose tolerance to NIDDM. An analysis of six prospective studies. Diabetes 1997; 46: 701-710.
5. Shaw J, Zimmet P, de Courten M, Dowse G, Chitson P, Gareeboo H et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes hi Mauritius? Diabetes Care 1999; 22: 399-402.
6. Alberti K. Impaired glucose tolerance - fact or fiction. Diabet Med 1996; 13: 6-8.
7. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
8. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A et al. High blood glucose concentration is a risk factor for mortality in middle-aged non-diabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21: 360-367.
9. Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 1998; 137: 565-573.
10. Lim S, Tai E, Tan B, Chew S, Tan C. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000; 23: 278-282.
11. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000; 43: 1470-1475.
12. Dowse G, Gareeboo H, Zimmet P, Alberti K, Tuomilehto J, Fareed D et al. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes 1990; 39: 390-396.
13. Dowse G, Gareeboo H, Alberti K, Zimmet P, Tuomilehto J, Purran A et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the noncommunicable disease intervention programme in Mauritius. BMJ 1995; 311: 1255-1259.
14. United Nations. World Population Prospects:The 1998 Revision: United Nations. Report no.: E.99.XIII.9. New York: United Nations, 1998.
15. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L et al. 1999 World Health Organization - International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21: 1009-1060.
16. Levy J, Matthews D, Hermans M. Correct homeostatic model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192.
17. Sekikawa A, Eguchi H, Tominaga M, Igarashi K, Abe T, Manaka H et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study. J Diabetes Complication 2000; 14: 78-83.
18. Harris M, Flegal K, Cowie C, Eberhardt M, Goldstein D, Little R et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination 1988-94. Diabetes Care 1998; 21: 518-524.
19. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen M, Tuomi T et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia study. Diabetes 2000; 49: 975-980.
20. Chen KT, Chen CJ, Gregg EW, Williamson DF, Narayan KM. High prevalence of impaired fasting glucose and type 2 diabetes mellitus in Penghu Islets, Taiwan: evidence of a rapidly emerging epidemic? Diabetes Res Clin Pract 1999; 44: 59-69.
21. Epidemiology and Disease Control Department, Ministry of Health Singapore. National Health Survey 1998 Singapore. Singapore: Ministry of Health, 1999.
22. Omar MA, Seedat MA, Dyer RB, Motala AA, Knight LT, Bccker PJ. South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 1994; 17: 70-73.
23. Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani AI, Bashir MI et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res Clin Pract 2000; 47: 135-146.
24. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
25. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157-177.
26. Larsson H, Berglund G, Lindgarde F, Ahren B. Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 1998; 41: 1124-1125.
27. Shaw J, de Courten M, Boyko E, Zimmet P. Impact of new diagnostic criteria for diabetes in different populations. Diabetes Care 1999; 22: 762-766.
28. Davies M, Raymond N, Day J, Hales C, Burden A. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabetes 2000; 17: 433-440.
29. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott DM. Relationships between insulin secretion, insulin action, and fasting glucose concentration in non-diabetic and non-insulin-dependent diabetic subjects. J Clin Invest 1984; 74: 1238-1246.
30. Weyer C, Bogardus C, Pratley R. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999; 48: 2197-2203.
31. Lillioja S. Impaired glucose tolerance in Pima Indians. Diabet Med 1996; 13: S127-S132.